These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3103519)

  • 1. [Current status of somatocrinin, or GRF, a hypothalamic growth hormone-secreting factor].
    Sassolas G; Guillemin R
    Ann Endocrinol (Paris); 1986; 47(5):332-41. PubMed ID: 3103519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone (GH)-releasing factor stimulates hypothalamic somatostatin release: an inhibitory feedback effect on GH secretion.
    Katakami H; Arimura A; Frohman LA
    Endocrinology; 1986 May; 118(5):1872-7. PubMed ID: 3084210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma growth hormone (GH) response to intravenous GH-releasing factor (GRF) in adult rats: evidence for transient pituitary desensitization after GRF stimulation.
    Arsenijevic Y; Rivest RW; Eshkol A; Sizonenko PC; Aubert ML
    Endocrinology; 1987 Oct; 121(4):1487-96. PubMed ID: 2888646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of species specificity in growth hormone-releasing factor (GRF) interaction with vasoactive intestinal peptide (VIP) receptors using GRF and intestinal VIP receptors from rat and human: evidence that Ac-Tyr1hGRF is a competitive VIP antagonist in the rat.
    Laburthe M; Couvineau A; Rouyer-Fessard C
    Mol Pharmacol; 1986 Jan; 29(1):23-7. PubMed ID: 3003561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GRF analogs and fragments: correlation between receptor binding, activity and structure.
    Campbell RM; Lee Y; Rivier J; Heimer EP; Felix AM; Mowles TF
    Peptides; 1991; 12(3):569-74. PubMed ID: 1656403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined effects of human growth hormone (GH)-releasing factor-44 (GRF) and somatostatin (SRIF) on post-SRIF rebound release of GH and prolactin: a model for GRF-SRIF modulation of secretion.
    Stachura ME; Tyler JM; Farmer PK
    Endocrinology; 1988 Sep; 123(3):1476-82. PubMed ID: 2900135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic growth hormone (GH) deficiency, and GH deficiency secondary to hypothalamic germinoma: effect of single and repeated administration of human GH-releasing factor (hGRF) on plasma GH level and endogenous hGRF-like immunoreactivity level in cerebrospinal fluid.
    Chihara K; Kashio Y; Abe H; Minamitani N; Kaji H; Kita T; Fujita T
    J Clin Endocrinol Metab; 1985 Feb; 60(2):269-78. PubMed ID: 3917456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1-40). Evidence for intermittent somatostatin secretion.
    Vance ML; Kaiser DL; Evans WS; Furlanetto R; Vale W; Rivier J; Thorner MO
    J Clin Invest; 1985 May; 75(5):1584-90. PubMed ID: 2860126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for direct action of estradiol on growth hormone-releasing factor (GRF) in rat hypothalamus: localization of [3H]estradiol in GRF neurons.
    Shirasu K; Stumpf WE; Sar M
    Endocrinology; 1990 Jul; 127(1):344-9. PubMed ID: 1972921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Somatocrinin induces growth hormone release in a case of growth hormone deficiency of hypothalamic origin in a child].
    Sassolas G; Rousset H; Cohen R; Chatelain P; Claustrat B; Laporte S; Laferrère B; El Charfi A; Ferry S
    C R Seances Acad Sci III; 1983; 296(11):527-30. PubMed ID: 6409361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological studies with somatocrinin, a growth hormone-releasing factor.
    Wehrenberg WB; Baird A; Zeytin F; Esch F; Böhlen P; Ling N; Ying SY; Guillemin R
    Annu Rev Pharmacol Toxicol; 1985; 25():463-83. PubMed ID: 2860847
    [No Abstract]   [Full Text] [Related]  

  • 12. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor.
    Olchovsky D; Bruno JF; Wood TL; Gelato MC; Leidy JW; Gilbert JM; Berelowitz M
    Endocrinology; 1990 Jan; 126(1):53-61. PubMed ID: 1967164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR structure of two novel polyethylene glycol conjugates of the human growth hormone-releasing factor, hGRF(1-29)-NH2.
    Digilio G; Barbero L; Bracco C; Corpillo D; Esposito P; Piquet G; Traversa S; Aime S
    J Am Chem Soc; 2003 Mar; 125(12):3458-70. PubMed ID: 12643708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog.
    Jetté L; Léger R; Thibaudeau K; Benquet C; Robitaille M; Pellerin I; Paradis V; van Wyk P; Pham K; Bridon DP
    Endocrinology; 2005 Jul; 146(7):3052-8. PubMed ID: 15817669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of somatostatin release in vitro by synthetic human growth hormone-releasing factor by a nondopaminergic mechanism.
    Aguila MC; McCann SM
    Endocrinology; 1985 Aug; 117(2):762-5. PubMed ID: 2862013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hypophysectomy on hypothalamic growth hormone-releasing factor content and release in the rat.
    Katakami H; Downs TR; Frohman LA
    Endocrinology; 1987 Mar; 120(3):1079-82. PubMed ID: 3100283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hGRF treatment of a patient with hGRF deficiency.
    Takano K; Hizuka N; Tanaka I; Shizume K
    Endocrinol Jpn; 1985 Aug; 32(4):511-6. PubMed ID: 3936701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of growth hormone-releasing factor (GRF) activity in the pituitary and hypothalamus of the conscious rat with a peptidic GRF antagonist.
    Lumpkin MD; McDonald JK
    Endocrinology; 1989 Mar; 124(3):1522-31. PubMed ID: 2537185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiological and clinical studies of GRF and GH.
    Thorner MO; Vance ML; Evans WS; Blizzard RM; Rogol AD; Ho K; Leong DA; Borges JL; Cronin MJ; MacLeod RM
    Recent Prog Horm Res; 1986; 42():589-640. PubMed ID: 3090660
    [No Abstract]   [Full Text] [Related]  

  • 20. Normal circulating immunoreactive growth hormone releasing factor (hGRF) concentrations in patients with functional hypothalamic hGRF deficiency.
    Sopwith AM; Penny ES; Grossman A; Savage MO; Besser GM; Rees LH
    Clin Endocrinol (Oxf); 1986 Apr; 24(4):395-400. PubMed ID: 2874905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.